Supply Issues B Braun Medical Ltd Hypodermic Luer Slip Syringe FWC068 (ICN 2227)

• The supply issue with FWC068 is ongoing.
• One product code remains affected in total.
• Due to this ongoing supply issue this product is now being threshold managed as it is subject to Protect Demand Management.
• FWC068 is available to order through NHS Supply Chain. However, trusts are allocated a maximum daily quantity or “threshold” to ensure fair supply of available stock across the NHS.
• Potential indirect alternative products are available to order through our online catalogue. However, some of these products may also become subject to intermittent supply with the increase in demand.
• See our Downloads ▼ section for a full list of product codes subject to Protect Demand Management and product listing for further information on the affected product code and potential alternatives.
• We will continue to review the stock to minimise further disruption. We will update this ICN as soon as we have further information.
• The supply issue is still anticipated to be resolved by 1 September 2023.

Change:

• The supplier B Braun Medical Ltd has informed us of a supply issue with its 10ml Hypodermic Luer Slip Syringe – FWC068.
• The supply issue is due to increased demand.

Impact:

• FWC068 is currently subject to intermittent supply.
• Potential indirect alternative products are available to order through our online catalogue:
  • FWC715 – Hypodermic Syringe 10ml Luer slip
  • FWC85170 – Hypodermic Syringe 10ml Luer Slip Concentric Blister Pack Sterile 3PC
  • FWC975 – Hypodermic Syringe 20ml Luer Slip Eccentric Clear Plunger Sterile.
• See our Downloads ▼ section to access the product listing for further information on the affected product code and potential alternatives.
• The supply issue is anticipated to be resolved by 1 September 2023.

Next Steps:              

• Customers are advised to log into our website to view the potential indirect alternative products.
• The continuing supply issue is being monitored in conjunction with the supplier and we will continue to monitor the stock situation to minimise further disruption.  We will update this ICN with the latest information as it becomes available.
• However, as this is currently a disrupted market and supply is subject to rapid change, the alternatives offered may also be experiencing temporary supply issues and therefore, customers may need to consider clinically reviewing all additional alternatives provided.
• If you have any further questions, please contact your local NHS Supply Chain Customer Services Advisor.

Please note that due to the clinical nature of these alternative products we advise you to consult your own clinical experts to ensure suitability for your organisations use of these products.